pharma in Japan Despite the FDA’s approval of an Alzheimer’s medication, Eisai drops 4%.
KEY POINTS Shares of Japanese pharmaceutical giant Eisai sank Friday after the…
Astellas Pharma of Japan has agreed to purchase IVERIC Bio for $5.9 billion.
Japan's Astellas Pharma said on Monday it agreed to buy U.S.-based drugmaker…